查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1666171

日本药品视觉检测系统市场 - 2025 年至 2033 年

Japan Pharmaceutical Visual Inspection Systems Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年日本药品视觉检测系统市场规模达到 5,427 万美元，预计到 2033 年将达到 1,136.5 亿美元，在 2025-2033 年预测期内的复合年增长率为 8.63%。

药品视觉检测系统是製药业用于检查产品品质和安全的专用技术和设备。这些系统旨在检测药品（包括药片、胶囊、小瓶、安瓿瓶和注射器）中的缺陷、污染或异常。

市场动态：

驱动因素与约束因素

越来越关注产品品质和安全

对产品品质和安全要求的日益关注是日本药品目视检测系统发展的重要推动力。随着製药业面临日本药品管理局（PMDA）和日本厚生劳动省等监管机构越来越严格的审查，企业被迫采用先进的检测技术，以确保符合严格的标准。

这些系统对于检测可能危及药物安全性和有效性的缺陷、污染物或不一致性至关重要。鑑于日本高品质製造的声誉和维护消费者信任的需要，製药公司正在投资最先进的视觉检测系统，利用人工智慧、机器学习和其他创新技术来提高准确性和效率。例如，2024 年 6 月，第一实业 Viswill 宣布将透过拥抱数位化并与全球领导者合作来继续突破创新的界限。这种对创新的承诺和影响推动着不断发展的视觉检测领域的卓越发展。

药品目视检测系统成本高

日本药品目视检测系统的高成本严重限制了其采用和实施，特别是对于预算有限的小公司而言。这些成本不仅包括对先进检测技术的初始投资，还包括与系统维护、校准和验证相关的持续费用，以满足各机构设定的严格监管标准。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 越来越关注产品品质和安全
    • 限制
      • 药品目视检测系统成本高
    • 机会
  • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：按机器类型

  • 自动的
  • 半自动
  • 手动的

第 7 章：按技术

  • 顶空气体分析 (HGA)
  • 高压洩漏检测 (HVLD)
  • 雷射折射
  • 其他的

第 8 章：按应用

  • 短期储存
  • 长期储存

第 9 章：按技术

  • 平板电脑
  • 胶囊
  • 软胶囊
  • 注射器
  • 安瓿
  • 西林瓶
  • 其他的

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Keyence Corporation
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Ikegami Tsushinki Co., Ltd.
  • Daiichi Jitsugyo Viswill Co., Ltd.
  • Hitachi Industry & Control Solutions, Ltd.
  • Stevanato Group SpA
  • Maquinaria Industrial Dara, SL
  • Qualicaps Co., Ltd.
  • VITRONIC Machine Vision GmbH
  • GFSpA
  • ViSCO Technologies Corporation
  • Similar data will be provided for each market player.

第 12 章：附录

简介目录
Product Code: MD9184

The Japan pharmaceutical visual inspection systems market reached US$ 54.27 million in 2024 and is expected to reach US$ 113.65 billion by 2033, growing at a CAGR of 8.63% during the forecast period 2025-2033.

Pharmaceutical Visual Inspection Systems are specialized technologies and equipment used in the pharmaceutical industry to inspect products for quality and safety. These systems are designed to detect defects, contamination, or irregularities in pharmaceutical products, including tablets, capsules, vials, ampoules, and syringes.

Market Dynamics: Drivers & Restraints

Growing Focus on Product Quality and Safety

The growing focus on product quality and safety requirements is a significant driver of pharmaceutical visual inspection systems in Japan. As the pharmaceutical industry faces increasing scrutiny from regulatory bodies such as the PMDA and the Ministry of Health, Labour, and Welfare, companies are compelled to adopt advanced inspection technologies to ensure compliance with stringent standards.

These systems are critical in detecting defects, contaminants, or inconsistencies that could compromise the safety and efficacy of pharmaceutical products. With Japan's reputation for high-quality manufacturing and the need to maintain consumer trust, pharmaceutical companies are investing in state-of-the-art visual inspection systems that utilize AI, machine learning, and other innovative technologies to enhance accuracy and efficiency. For instance, in June 2024, Daiichi Jitsugyo Viswill announced that it continues to push the boundaries of innovation by embracing digitalization and partnering with global leaders. This type of commitment to innovation and influences excellence in the ever-evolving field of visual inspection.

High cost associated with pharmaceutical visual inspection systems

The high cost associated with pharmaceutical visual inspection systems in Japan significantly restrains their adoption and implementation, particularly for smaller companies with limited budgets. These costs encompass not only the initial investment in advanced inspection technology but also the ongoing expenses related to system maintenance, calibration, and validation to meet stringent regulatory standards set by various agencies.

Segment Analysis

The Japan pharmaceutical visual inspection systems market is segmented based on machine type, technology, and application.

Product Type:

Automated inspection systems segment is expected to dominate the Japan pharmaceutical visual inspection systems market share

Automated inspection systems are a significant market player, focusing on efficiency and precision in quality control processes. They use robotics, machine learning, and high-resolution imaging to reduce human error and increase throughput. Analytical inspection, on the other hand, involves detailed analysis of pharmaceutical formulations using spectrometers and chromatographs. These inspections aim to enhance product reliability and regulatory compliance, driving innovation and adoption of advanced technologies in the Japanese pharmaceutical sector.

Automatic visual inspection systems (AVIS) are crucial in Japan's pharmaceutical industry for ensuring injectable product quality and safety. They use advanced technologies like machine vision and AI to automate inspection processes, ensuring regulatory compliance.

Japan's regulatory bodies mandate rigorous visual inspection of parenteral products to detect defects and foreign particulate matter (FPM), with 100% of containers required. AVIS systems, using high-resolution cameras and sophisticated image processing algorithms, can identify defects like cosmetic flaws, particulate contamination, and packaging defects. These systems can detect even minor anomalies that human inspectors might overlook, ensuring high product quality and patient safety.

Competitive Landscape

The major players in the Japan pharmaceutical visual inspection systems include Keyence Corporation, Ikegami Tsushinki Co., Ltd., Daiichi Jitsugyo Viswill Co., Ltd., Hitachi Industry & Control Solutions, Ltd., Stevanato Group SpA, Maquinaria Industrial Dara, S.L., Qualicaps Co., Ltd., VITRONIC Machine Vision GmbH, G.F. S.p.A. and ViSCO Technologies Corporation among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Pharmaceutical Visual Inspection Systems Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Machine Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Focus on Product Quality and Safety
    • 4.1.2. Restraints
      • 4.1.2.1. High cost associated with pharmaceutical visual inspection systems
    • 4.1.3. Opportunity
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Machine Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Machine Type
    • 6.1.2. Market Attractiveness Index, By Machine Type
  • 6.2. Automatic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Semi-Automatic
  • 6.4. Manual

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Headspace Gas Analysis (HGA)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. High Voltage Leak Detection (HVLD)
  • 7.4. Laser Refraction
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Short-Term Storage*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Long-Term Storage

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Tablets*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Capsules
  • 9.4. Soft Gels
  • 9.5. Syringes
  • 9.6. Ampoules
  • 9.7. Vials
  • 9.8. Others

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Keyence Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Ikegami Tsushinki Co., Ltd.
  • 11.3. Daiichi Jitsugyo Viswill Co., Ltd.
  • 11.4. Hitachi Industry & Control Solutions, Ltd.
  • 11.5. Stevanato Group SpA
  • 11.6. Maquinaria Industrial Dara, S.L.
  • 11.7. Qualicaps Co., Ltd.
  • 11.8. VITRONIC Machine Vision GmbH
  • 11.9. G.F. S.p.A.
  • 11.10. ViSCO Technologies Corporation
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us